Forum Financial Management’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78K Hold
30,100
﹤0.01% 343
2026
Q1
$92.4K Sell
30,100
-40
-0.1% -$173 ﹤0.01% 318
2025
Q4
$107K Hold
30,140
﹤0.01% 993
2025
Q3
$268K Hold
30,140
﹤0.01% 800
2025
Q2
$278K Hold
30,140
﹤0.01% 714
2025
Q1
$259K Buy
+30,140
New +$285K ﹤0.01% 673
2024
Q4
Sell
-35,140
Closed -$200K 922
2024
Q3
$200K Buy
+35,140
New +$203K ﹤0.01% 727

Other funds holding AVXL

Forum Financial Management's AVXL Position: Q2 2026 in Review

Forum Financial Management held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 30,100 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Forum Financial Management first reported a position in AVXL in Q3 2024 and has held it in 7 quarters since. The position peaked at $278K in Q2 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Forum Financial Management held 30,100 shares of Anavex Life Sciences worth $78K as of Q2 2026.
  • Forum Financial Management left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Forum Financial Management's portfolio in Q2 2026, its #343 holding.
  • Forum Financial Management first reported a position in Anavex Life Sciences in Q3 2024 and has held it in 7 quarters since.
  • Forum Financial Management's Anavex Life Sciences position peaked at $278K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Forum Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.